MAGEC1 wt Allele

Known as: Melanoma Antigen Family C, 1 wt Allele, MAGE-C1, CT7 
Human MAGEC1 wild-type allele is located in the vicinity of Xq26 and is approximately 6 kb in length. This allele, which encodes melanoma-associated… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1987-2015
012319872015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
259/2; CT7/590/7; CT7/683/9) recognized CT7-pulsed DC, thus demonstrating that the peptides recognized by the CD4þ T-cell clones… (More)
  • figure 1
  • figure 2
Is this relevant?
2008
2008
Neutralization of invading pathogens by gene-encoded peptide antibiotics has been suggested to manifest in a variety of different… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2008
2008
Medulloblastoma is the most common childhood malignant tumor of the central nervous system. Treatment of medulloblastoma requires… (More)
Is this relevant?
2007
2007
High expression of the cancer-testis antigen CT7, also referred to as MAGE-C1, has been recently described in a variety of… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2007
2007
We analysed two different neural mechanisms related to the unconscious processing of auditory stimulation, neural adaptation and… (More)
Is this relevant?
2006
2006
Cancer/testis (CT) antigens are the protein products of germ line-associated genes that are activated in a wide variety of tumors… (More)
Is this relevant?
2004
2004
BACKGROUND Cancer testis antigens (CTAs) are T-cell-defined tumor-associated antigens encoded by the genes and gene families such… (More)
Is this relevant?
Review
2004
Review
2004
6554 Background: CT7 (MAGE-C1) is a member of the Cancer-Testis (CT) family of tumor-associated antigens. CT antigen-based… (More)
Is this relevant?
2002
2002
CT7 (MAGE-C1) is a member of the cancer testis (CT) antigen family. The present study describes the generation of CT7-33, a… (More)
Is this relevant?
1999
1999
BACKGROUND AND PURPOSE Growing experimental evidence indicates that the development of cerebral ischemic damage is slower than… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?